Trials / No Longer Available
No Longer AvailableNCT04855955
Autologous Human Adipose-Derived Mesenchymal Stem Cells in Alzheimer's Disease
Individual Patient Expanded Access Investigation New Drug (IND) Application for Administration of Autologous Human Adipose-Derived Mesenchymal Stem Cells in Alzheimer's Disease
- Status
- No Longer Available
- Phase
- —
- Study type
- Expanded Access
- Enrollment
- —
- Sponsor
- Celltex Therapeutics Corporation · Industry
- Sex
- —
- Age
- —
- Healthy volunteers
- —
Summary
This is a single patient emergency expanded access clinical study to assess the safety of administering autologous AdMSCs to an incurable Alzheimer disease patient. The study subject will be evaluated for disease-associated severity according to symptoms, cognitive function, memory, and quality of life.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Adipose-Derived Mesenchymal Stem Cells |
Timeline
- First posted
- 2021-04-22
- Last updated
- 2024-02-07
Source: ClinicalTrials.gov record NCT04855955. Inclusion in this directory is not an endorsement.